Jason L. Hornick, MD, PhD, FCAP, discusses the strengths – and limitations – of IHC as a stand-in for molecular testing. Diagnosing soft tissue tumors remains challenging, but a new review published by the College of American Pathologists (CAP) offers practical guidance for pathologists.
For the full article click here: Surrogates with Substance: Decoding Soft Tissue Tumors